Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30030021HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30030022HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30030023HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30030024HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS20010786HPVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS20010805HPVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS44023294HTLV-1ENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS44020453HTLV-1ENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS44050877HTLV-1ENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TCGA Plot Options
Drug Information
GenePOLA2
DrugBank IDDB00851
Drug NameDacarbazine
Target IDBE0000716
UniProt IDQ14181
Regulation Typeother/unknown
PubMed IDs17139284; 17016423; 3098406
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Lonn U, Lohn S: Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin. Cancer Res. 1987 Jan 1;47(1):26-30.
GroupsApproved; Investigational
Direct Classification2-heteroaryl carboxamides
SMILESCN(C)N=NC1=C(N=CN1)C(N)=O
Pathways
PharmGKBPA449197
ChEMBLCHEMBL476